Xenetic Biosciences Inc

-0.05 (-7.69%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)7.75M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.35 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$0.65
50-Day MA$0.80
200-Day MA$0.93
See more pivots

Xenetic Biosciences Inc Stock, NASDAQ:XBIO

40 Speen Street, Suite 102, Framingham, Massachusetts 01701
United States of America
Phone: +1.781.778.7720
Number of Employees: 4


Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patientâ??s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.